Company intelligence / Profile preview

Momenta Pharmaceuticals

Cambridge, Massachusetts, United Statesjnj.com ↗

Ownership: Private
Employees: ~300
Development stage: Commercial

Overview

Momenta developed a diversified pipeline including novel therapeutics for immune-mediated diseases as well as biosimilars and complex generics. Its lead program M281 targeted the neonatal Fc receptor for rare autoimmune disorders. The company successfully commercialized generic versions of Lovenox® (enoxaparin sodium) and Copaxone® (glatiramer acetate) before being acquired by Johnson & Johnson in 2020 for $6.5 billion

Therapeutic areas: CardiovascularImmunologyHematologyOncologyNeurology
Modalities: Monoclonal antibodies (mAbs)biosimilarscomplex genericsglycoproteins
Industry: Biotech

Drug pipeline

3 assets

nipocalimab

NDA

Indications: Myasthenia gravis, Hemolytic diseases of fetus and newborn, Autoimmune hemolytic anemia

2 more assets in the full pipeline.

Request access →

Partnerships

Sandoz AG/NovartisMylan Ireland LimitedCSL Behring Recombinant Facility AG [for biosimilars/generics development/licensing]

Beyond the preview

Go deeper on Momenta Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Momenta Pharmaceuticals.

Explore the full profile